Rank | Gene Set | Z-score |
---|---|---|
1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 7.83062398 |
2 | tricarboxylic acid cycle (GO:0006099) | 7.14962877 |
3 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 7.11721461 |
4 | ATP synthesis coupled proton transport (GO:0015986) | 7.11721461 |
5 | * respiratory electron transport chain (GO:0022904) | 6.66164929 |
6 | * mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 6.54603241 |
7 | * electron transport chain (GO:0022900) | 6.48387915 |
8 | oxidative phosphorylation (GO:0006119) | 6.07980432 |
9 | NADH metabolic process (GO:0006734) | 5.54556416 |
10 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.46947317 |
11 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 5.24670920 |
12 | sarcomere organization (GO:0045214) | 5.16172503 |
13 | regulation of cofactor metabolic process (GO:0051193) | 4.96072471 |
14 | regulation of coenzyme metabolic process (GO:0051196) | 4.96072471 |
15 | lysine metabolic process (GO:0006553) | 4.81670250 |
16 | lysine catabolic process (GO:0006554) | 4.81670250 |
17 | succinate metabolic process (GO:0006105) | 4.74086127 |
18 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.62812758 |
19 | carnitine shuttle (GO:0006853) | 4.54198910 |
20 | cardiac myofibril assembly (GO:0055003) | 4.50586495 |
21 | ATP biosynthetic process (GO:0006754) | 4.43685022 |
22 | creatine metabolic process (GO:0006600) | 4.40629954 |
23 | fatty acid beta-oxidation (GO:0006635) | 4.30669293 |
24 | muscle filament sliding (GO:0030049) | 4.26603544 |
25 | actin-myosin filament sliding (GO:0033275) | 4.26603544 |
26 | aspartate family amino acid catabolic process (GO:0009068) | 4.25744338 |
27 | gluconeogenesis (GO:0006094) | 4.25173199 |
28 | ubiquinone biosynthetic process (GO:0006744) | 4.25006274 |
29 | quinone biosynthetic process (GO:1901663) | 4.25006274 |
30 | 2-oxoglutarate metabolic process (GO:0006103) | 4.24719293 |
31 | oxaloacetate metabolic process (GO:0006107) | 4.23952324 |
32 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.22611000 |
33 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.21679004 |
34 | fatty acid transmembrane transport (GO:1902001) | 4.18932504 |
35 | branched-chain amino acid catabolic process (GO:0009083) | 4.17435328 |
36 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.15792719 |
37 | cardiac muscle contraction (GO:0060048) | 4.15700527 |
38 | cellular ketone body metabolic process (GO:0046950) | 4.11256748 |
39 | inner mitochondrial membrane organization (GO:0007007) | 4.09002865 |
40 | myofibril assembly (GO:0030239) | 4.00765827 |
41 | aerobic respiration (GO:0009060) | 3.97315748 |
42 | regulation of sequestering of triglyceride (GO:0010889) | 3.90255509 |
43 | regulation of sulfur metabolic process (GO:0042762) | 3.85984627 |
44 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.85692404 |
45 | NADH dehydrogenase complex assembly (GO:0010257) | 3.85692404 |
46 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.85692404 |
47 | hexose biosynthetic process (GO:0019319) | 3.85453675 |
48 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.85033713 |
49 | protein complex biogenesis (GO:0070271) | 3.83797801 |
50 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.82457124 |
51 | fatty acid catabolic process (GO:0009062) | 3.81414968 |
52 | ubiquinone metabolic process (GO:0006743) | 3.77120462 |
53 | heart process (GO:0003015) | 3.75260600 |
54 | heart contraction (GO:0060047) | 3.75260600 |
55 | acetyl-CoA metabolic process (GO:0006084) | 3.73883275 |
56 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.71972034 |
57 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.71410770 |
58 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.70883293 |
59 | regulation of relaxation of muscle (GO:1901077) | 3.70354641 |
60 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.69722018 |
61 | tricarboxylic acid metabolic process (GO:0072350) | 3.69620367 |
62 | short-chain fatty acid metabolic process (GO:0046459) | 3.69446678 |
63 | branched-chain amino acid metabolic process (GO:0009081) | 3.68842351 |
64 | fatty acid oxidation (GO:0019395) | 3.66345150 |
65 | regulation of mitochondrial translation (GO:0070129) | 3.62176754 |
66 | monosaccharide biosynthetic process (GO:0046364) | 3.60669349 |
67 | ketone body metabolic process (GO:1902224) | 3.58617090 |
68 | lipid oxidation (GO:0034440) | 3.58357118 |
69 | cardiac muscle cell development (GO:0055013) | 3.52942726 |
70 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.51309127 |
71 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.50123950 |
72 | aldehyde catabolic process (GO:0046185) | 3.48802006 |
73 | regulation of cell communication by electrical coupling (GO:0010649) | 3.47638814 |
74 | carnitine transmembrane transport (GO:1902603) | 3.46891040 |
75 | hydrogen ion transmembrane transport (GO:1902600) | 3.43691387 |
76 | carnitine transport (GO:0015879) | 3.41921847 |
77 | amino-acid betaine transport (GO:0015838) | 3.41921847 |
78 | regulation of actin filament-based movement (GO:1903115) | 3.41422296 |
79 | actin-mediated cell contraction (GO:0070252) | 3.39589051 |
80 | regulation of fatty acid oxidation (GO:0046320) | 3.39164112 |
81 | dicarboxylic acid catabolic process (GO:0043649) | 3.38903150 |
82 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.37692999 |
83 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.37058571 |
84 | glyoxylate metabolic process (GO:0046487) | 3.36079216 |
85 | cellular respiration (GO:0045333) | 3.34758922 |
86 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 3.34686729 |
87 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.33661805 |
88 | monocarboxylic acid catabolic process (GO:0072329) | 3.33360083 |
89 | regulation of skeletal muscle contraction (GO:0014819) | 3.32800443 |
90 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.32251695 |
91 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 3.30663348 |
92 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 3.30663348 |
93 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.29055808 |
94 | L-phenylalanine metabolic process (GO:0006558) | 3.25173233 |
95 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.25173233 |
96 | carnitine metabolic process (GO:0009437) | 3.22821211 |
97 | cardiac cell development (GO:0055006) | 3.21091524 |
98 | regulation of oxidative phosphorylation (GO:0002082) | 3.20859922 |
99 | mitochondrial transport (GO:0006839) | 3.17641351 |
100 | striated muscle contraction (GO:0006941) | 3.17307826 |
101 | ADP metabolic process (GO:0046031) | 3.16915868 |
102 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.13525380 |
103 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.11863056 |
104 | L-phenylalanine catabolic process (GO:0006559) | 3.11863056 |
105 | COPI coating of Golgi vesicle (GO:0048205) | 3.10428792 |
106 | Golgi transport vesicle coating (GO:0048200) | 3.10428792 |
107 | glycolytic process (GO:0006096) | 3.09956160 |
108 | proline biosynthetic process (GO:0006561) | 3.07069491 |
109 | skeletal muscle contraction (GO:0003009) | 3.05388720 |
110 | heart trabecula formation (GO:0060347) | 3.04892974 |
111 | valine metabolic process (GO:0006573) | 3.04863691 |
112 | regulation of cellular respiration (GO:0043457) | 3.04453078 |
113 | * generation of precursor metabolites and energy (GO:0006091) | 3.01408226 |
114 | plasma membrane repair (GO:0001778) | 3.00189319 |
115 | fructose metabolic process (GO:0006000) | 2.99667652 |
116 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.98697799 |
117 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.98486560 |
118 | muscle tissue morphogenesis (GO:0060415) | 2.97957655 |
119 | biotin metabolic process (GO:0006768) | 2.95525489 |
120 | nucleoside triphosphate biosynthetic process (GO:0009142) | 2.94872953 |
121 | glycogen catabolic process (GO:0005980) | 2.89958493 |
122 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.89140607 |
123 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.89140607 |
124 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.87805806 |
125 | AMP metabolic process (GO:0046033) | 2.86682828 |
126 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.86149893 |
127 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.78212924 |
128 | cell communication involved in cardiac conduction (GO:0086065) | 2.77327835 |
129 | cullin deneddylation (GO:0010388) | 2.77054040 |
130 | pyruvate metabolic process (GO:0006090) | 2.75843032 |
131 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.75186720 |
132 | muscle cell cellular homeostasis (GO:0046716) | 2.69567575 |
133 | glutamate metabolic process (GO:0006536) | 2.68393229 |
134 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.68134084 |
135 | proline metabolic process (GO:0006560) | 2.62736309 |
136 | glucan catabolic process (GO:0009251) | 2.58924610 |
137 | positive regulation of mitochondrial fission (GO:0090141) | 2.57218185 |
138 | cardiac muscle hypertrophy (GO:0003300) | 2.55904358 |
139 | striated muscle hypertrophy (GO:0014897) | 2.55189616 |
140 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.54795473 |
141 | regulation of cholesterol esterification (GO:0010872) | 2.53743113 |
142 | glucan biosynthetic process (GO:0009250) | 2.53549198 |
143 | glycogen biosynthetic process (GO:0005978) | 2.53549198 |
144 | cell communication by electrical coupling (GO:0010644) | 2.51755390 |
145 | detection of calcium ion (GO:0005513) | 2.51706810 |
146 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.50723710 |
147 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.49731064 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 8.14900067 |
2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.27039125 |
3 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.96397857 |
4 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.04536154 |
5 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.99137173 |
6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.47774356 |
7 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.01346745 |
8 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.95690487 |
9 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.92068802 |
10 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.91159496 |
11 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.84015168 |
12 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.72040935 |
13 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.65973508 |
14 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.65784090 |
15 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.45105965 |
16 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.35249236 |
17 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.30771226 |
18 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.24893580 |
19 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.18871070 |
20 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.17258284 |
21 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.17246217 |
22 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.12921808 |
23 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.11377595 |
24 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.10700615 |
25 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.01222552 |
26 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.00111437 |
27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.93538077 |
28 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.91083086 |
29 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.87478877 |
30 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.82593374 |
31 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.81063990 |
32 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.79925109 |
33 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.76091891 |
34 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.70455396 |
35 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.63683499 |
36 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.63365622 |
37 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.61449896 |
38 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.58445263 |
39 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.58408059 |
40 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.57970068 |
41 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 1.57328434 |
42 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.56056979 |
43 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.55871407 |
44 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.54862050 |
45 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.54583949 |
46 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.53293716 |
47 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.52105859 |
48 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.47503002 |
49 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.46661119 |
50 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.44127036 |
51 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.43045234 |
52 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.42278934 |
53 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.40727440 |
54 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.38970549 |
55 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.38293072 |
56 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.37303852 |
57 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.36316166 |
58 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.34652430 |
59 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.34652430 |
60 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.33528059 |
61 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.30156715 |
62 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.27016925 |
63 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.26765181 |
64 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.26560720 |
65 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.26415177 |
66 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.23408899 |
67 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.22484920 |
68 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.21154516 |
69 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.18623385 |
70 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.17600264 |
71 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.16596877 |
72 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.16460325 |
73 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.13775087 |
74 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.13770581 |
75 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13342558 |
76 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12011157 |
77 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.10361046 |
78 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.10332128 |
79 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.07926675 |
80 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.06221878 |
81 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.04243156 |
82 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.01654404 |
83 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.00085323 |
84 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.99346375 |
85 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.99341917 |
86 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.99276323 |
87 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.98934904 |
88 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.98525529 |
89 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.98368736 |
90 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.97500917 |
91 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.96833002 |
92 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.96078532 |
93 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.93043621 |
94 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.92817456 |
95 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.91402674 |
96 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.90889157 |
97 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.90239506 |
98 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.89966209 |
99 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.88128957 |
100 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.87635797 |
101 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.86766875 |
102 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.85185373 |
103 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.84900928 |
104 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.84119750 |
105 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.83098024 |
106 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.83088654 |
107 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.82105040 |
108 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.82094467 |
109 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.81211534 |
110 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.80526075 |
111 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.79713987 |
112 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.79568139 |
113 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79159537 |
114 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.77284459 |
115 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.76379091 |
116 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.76341724 |
117 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.74728670 |
118 | * P68_20966046_ChIP-Seq_HELA_Human | 0.74611086 |
119 | ERA_21632823_ChIP-Seq_H3396_Human | 0.74497079 |
120 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.74172160 |
121 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.73984628 |
122 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.73386122 |
123 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.73250115 |
124 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.72630676 |
125 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.72542915 |
126 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.71884529 |
127 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.70882136 |
128 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.69584739 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002837_dystrophic_cardiac_calcinosis | 6.06555523 |
2 | MP0003646_muscle_fatigue | 5.22568067 |
3 | MP0004084_abnormal_cardiac_muscle | 4.20232493 |
4 | MP0000751_myopathy | 4.14149542 |
5 | MP0004215_abnormal_myocardial_fiber | 4.00602519 |
6 | MP0005330_cardiomyopathy | 3.46669692 |
7 | MP0000749_muscle_degeneration | 3.42184435 |
8 | MP0004036_abnormal_muscle_relaxation | 3.40416713 |
9 | MP0006036_abnormal_mitochondrial_physio | 3.29354922 |
10 | MP0003806_abnormal_nucleotide_metabolis | 2.91388082 |
11 | MP0005360_urolithiasis | 2.73200814 |
12 | MP0004270_analgesia | 2.60167647 |
13 | MP0004859_abnormal_synaptic_plasticity | 2.58501141 |
14 | MP0002139_abnormal_hepatobiliary_system | 2.51085353 |
15 | MP0002972_abnormal_cardiac_muscle | 2.48862623 |
16 | MP0008775_abnormal_heart_ventricle | 2.43953361 |
17 | MP0004087_abnormal_muscle_fiber | 2.40064857 |
18 | MP0003137_abnormal_impulse_conducting | 2.34807719 |
19 | MP0004130_abnormal_muscle_cell | 2.31650642 |
20 | MP0003880_abnormal_central_pattern | 2.31021282 |
21 | MP0005085_abnormal_gallbladder_physiolo | 2.29436117 |
22 | MP0005620_abnormal_muscle_contractility | 2.25567600 |
23 | MP0006035_abnormal_mitochondrial_morpho | 2.14187647 |
24 | MP0005385_cardiovascular_system_phenoty | 2.12430363 |
25 | MP0001544_abnormal_cardiovascular_syste | 2.12430363 |
26 | MP0002269_muscular_atrophy | 2.09854927 |
27 | MP0003221_abnormal_cardiomyocyte_apopto | 2.07114658 |
28 | MP0000750_abnormal_muscle_regeneration | 2.03800616 |
29 | MP0004484_altered_response_of | 1.97252122 |
30 | MP0004145_abnormal_muscle_electrophysio | 1.94152131 |
31 | MP0002106_abnormal_muscle_physiology | 1.93938243 |
32 | MP0000747_muscle_weakness | 1.91935294 |
33 | MP0006138_congestive_heart_failure | 1.90285847 |
34 | MP0001984_abnormal_olfaction | 1.89384441 |
35 | MP0005332_abnormal_amino_acid | 1.87568435 |
36 | MP0005058_abnormal_lysosome_morphology | 1.82750631 |
37 | MP0010630_abnormal_cardiac_muscle | 1.77250991 |
38 | MP0005670_abnormal_white_adipose | 1.72092475 |
39 | MP0001661_extended_life_span | 1.70348467 |
40 | MP0005365_abnormal_bile_salt | 1.70253487 |
41 | MP0008260_abnormal_autophagy | 1.66760535 |
42 | MP0004085_abnormal_heartbeat | 1.66484698 |
43 | MP0005666_abnormal_adipose_tissue | 1.64776665 |
44 | MP0008875_abnormal_xenobiotic_pharmacok | 1.63601902 |
45 | MP0000759_abnormal_skeletal_muscle | 1.60905344 |
46 | MP0000003_abnormal_adipose_tissue | 1.58990194 |
47 | MP0005423_abnormal_somatic_nervous | 1.54238253 |
48 | MP0005369_muscle_phenotype | 1.53039611 |
49 | MP0002064_seizures | 1.43881121 |
50 | MP0009046_muscle_twitch | 1.41684519 |
51 | MP0004043_abnormal_pH_regulation | 1.39559243 |
52 | MP0002332_abnormal_exercise_endurance | 1.39195376 |
53 | MP0003195_calcinosis | 1.37939514 |
54 | MP0004147_increased_porphyrin_level | 1.37772692 |
55 | MP0009840_abnormal_foam_cell | 1.37444659 |
56 | MP0004233_abnormal_muscle_weight | 1.33807321 |
57 | MP0003186_abnormal_redox_activity | 1.33116709 |
58 | MP0002822_catalepsy | 1.29424552 |
59 | MP0005266_abnormal_metabolism | 1.28678858 |
60 | MP0002127_abnormal_cardiovascular_syste | 1.27582894 |
61 | MP0005083_abnormal_biliary_tract | 1.27462810 |
62 | MP0003828_pulmonary_edema | 1.24190554 |
63 | MP0003635_abnormal_synaptic_transmissio | 1.21823627 |
64 | MP0008569_lethality_at_weaning | 1.21597492 |
65 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.21367314 |
66 | MP0009780_abnormal_chondrocyte_physiolo | 1.21343725 |
67 | MP0009379_abnormal_foot_pigmentation | 1.20775181 |
68 | MP0005319_abnormal_enzyme/_coenzyme | 1.20458678 |
69 | MP0002090_abnormal_vision | 1.18474926 |
70 | MP0010329_abnormal_lipoprotein_level | 1.17257293 |
71 | MP0005451_abnormal_body_composition | 1.16883494 |
72 | MP0005535_abnormal_body_temperature | 1.12608290 |
73 | MP0002272_abnormal_nervous_system | 1.09240449 |
74 | MP0002971_abnormal_brown_adipose | 1.07946717 |
75 | MP0004185_abnormal_adipocyte_glucose | 1.04942593 |
76 | MP0003879_abnormal_hair_cell | 1.03504297 |
77 | MP0002734_abnormal_mechanical_nocicepti | 1.02241860 |
78 | MP0001529_abnormal_vocalization | 1.02048323 |
79 | MP0002118_abnormal_lipid_homeostasis | 1.01693557 |
80 | MP0001764_abnormal_homeostasis | 1.00540941 |
81 | MP0000230_abnormal_systemic_arterial | 0.99021979 |
82 | MP0008058_abnormal_DNA_repair | 0.96850582 |
83 | MP0003656_abnormal_erythrocyte_physiolo | 0.95747035 |
84 | MP0003567_abnormal_fetal_cardiomyocyte | 0.94716815 |
85 | MP0009745_abnormal_behavioral_response | 0.94183478 |
86 | MP0005165_increased_susceptibility_to | 0.94071989 |
87 | MP0005646_abnormal_pituitary_gland | 0.90656559 |
88 | MP0005375_adipose_tissue_phenotype | 0.90315666 |
89 | MP0009643_abnormal_urine_homeostasis | 0.86902291 |
90 | MP0005636_abnormal_mineral_homeostasis | 0.80838039 |
91 | MP0002063_abnormal_learning/memory/cond | 0.80629940 |
92 | MP0003868_abnormal_feces_composition | 0.80049608 |
93 | MP0002066_abnormal_motor_capabilities/c | 0.79077296 |
94 | MP0001346_abnormal_lacrimal_gland | 0.78058448 |
95 | MP0002078_abnormal_glucose_homeostasis | 0.77870115 |
96 | MP0003111_abnormal_nucleus_morphology | 0.76130165 |
97 | MP0003786_premature_aging | 0.75952902 |
98 | MP0003690_abnormal_glial_cell | 0.75889435 |
99 | MP0000343_altered_response_to | 0.75101712 |
100 | MP0008007_abnormal_cellular_replicative | 0.72599892 |
101 | MP0000920_abnormal_myelination | 0.72372834 |
102 | MP0005187_abnormal_penis_morphology | 0.71664313 |
103 | MP0008995_early_reproductive_senescence | 0.71589559 |
104 | MP0005376_homeostasis/metabolism_phenot | 0.71291175 |
105 | MP0001666_abnormal_nutrient_absorption | 0.71077001 |
106 | MP0000604_amyloidosis | 0.70217387 |
107 | MP0001486_abnormal_startle_reflex | 0.70170146 |
108 | MP0003950_abnormal_plasma_membrane | 0.70164371 |
109 | MP0004510_myositis | 0.70094954 |
110 | MP0001501_abnormal_sleep_pattern | 0.70076095 |
111 | MP0002876_abnormal_thyroid_physiology | 0.69947295 |
112 | MP0002229_neurodegeneration | 0.69810272 |
113 | MP0006276_abnormal_autonomic_nervous | 0.69460560 |
114 | MP0003191_abnormal_cellular_cholesterol | 0.68953624 |
115 | MP0000013_abnormal_adipose_tissue | 0.68103428 |
116 | MP0000266_abnormal_heart_morphology | 0.66800446 |
117 | MP0000609_abnormal_liver_physiology | 0.66554766 |
118 | MP0003329_amyloid_beta_deposits | 0.64613625 |
119 | MP0002736_abnormal_nociception_after | 0.64363298 |
120 | MP0005386_behavior/neurological_phenoty | 0.62899070 |
121 | MP0004924_abnormal_behavior | 0.62899070 |
122 | MP0003252_abnormal_bile_duct | 0.62270992 |
123 | MP0000358_abnormal_cell_content/ | 0.60410883 |
124 | MP0004142_abnormal_muscle_tone | 0.58756617 |
125 | MP0001756_abnormal_urination | 0.54238788 |
126 | MP0003011_delayed_dark_adaptation | 0.53415746 |
127 | MP0005334_abnormal_fat_pad | 0.51953850 |
128 | MP0002970_abnormal_white_adipose | 0.51887010 |
129 | MP0002735_abnormal_chemical_nociception | 0.50796071 |
130 | MP0001765_abnormal_ion_homeostasis | 0.48816569 |
131 | MP0005452_abnormal_adipose_tissue | 0.47985702 |
132 | MP0009697_abnormal_copulation | 0.47599749 |
133 | MP0008872_abnormal_physiological_respon | 0.47447184 |
134 | MP0005448_abnormal_energy_balance | 0.45854473 |
135 | MP0002909_abnormal_adrenal_gland | 0.45267692 |
136 | MP0001968_abnormal_touch/_nociception | 0.43202701 |
137 | MP0004019_abnormal_vitamin_homeostasis | 0.42188852 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.25293353 |
2 | Acute necrotizing encephalopathy (HP:0006965) | 5.24976135 |
3 | Sudden death (HP:0001699) | 5.21703908 |
4 | * Hepatic necrosis (HP:0002605) | 5.03213297 |
5 | Acute encephalopathy (HP:0006846) | 4.88693642 |
6 | Nemaline bodies (HP:0003798) | 4.88267519 |
7 | Muscle fiber inclusion bodies (HP:0100299) | 4.85889869 |
8 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.75242047 |
9 | * Hepatocellular necrosis (HP:0001404) | 4.70133780 |
10 | * Mitochondrial inheritance (HP:0001427) | 4.65058007 |
11 | Myoglobinuria (HP:0002913) | 4.57674983 |
12 | * Increased CSF lactate (HP:0002490) | 4.41002075 |
13 | Progressive macrocephaly (HP:0004481) | 4.37908888 |
14 | Increased muscle lipid content (HP:0009058) | 4.33499830 |
15 | Cerebral edema (HP:0002181) | 4.31505586 |
16 | Exercise-induced myalgia (HP:0003738) | 4.16754302 |
17 | Calf muscle hypertrophy (HP:0008981) | 4.13672626 |
18 | Ventricular tachycardia (HP:0004756) | 4.05417799 |
19 | Increased intramyocellular lipid droplets (HP:0012240) | 4.04050766 |
20 | Rhabdomyolysis (HP:0003201) | 3.98962082 |
21 | Abnormality of glycolysis (HP:0004366) | 3.93463935 |
22 | Increased serum pyruvate (HP:0003542) | 3.93463935 |
23 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.89073882 |
24 | Exercise-induced muscle cramps (HP:0003710) | 3.87125983 |
25 | * Lactic acidosis (HP:0003128) | 3.82943728 |
26 | Palpitations (HP:0001962) | 3.77409166 |
27 | Lipid accumulation in hepatocytes (HP:0006561) | 3.70083258 |
28 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.68167877 |
29 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.68167877 |
30 | Dicarboxylic aciduria (HP:0003215) | 3.62868381 |
31 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.62868381 |
32 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.61646564 |
33 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.41590663 |
34 | Lipoatrophy (HP:0100578) | 3.40768045 |
35 | Exercise intolerance (HP:0003546) | 3.39607687 |
36 | Atrial fibrillation (HP:0005110) | 3.38639799 |
37 | * Respiratory failure (HP:0002878) | 3.36927414 |
38 | Increased hepatocellular lipid droplets (HP:0006565) | 3.33452407 |
39 | Rimmed vacuoles (HP:0003805) | 3.32910507 |
40 | Ketoacidosis (HP:0001993) | 3.30260116 |
41 | Abnormality of the calf musculature (HP:0001430) | 3.22098141 |
42 | Hypoglycemic coma (HP:0001325) | 3.21643446 |
43 | Hyperglycinuria (HP:0003108) | 3.19738351 |
44 | Hyperammonemia (HP:0001987) | 3.18499985 |
45 | * Increased serum lactate (HP:0002151) | 3.17956755 |
46 | Supraventricular tachycardia (HP:0004755) | 3.17891784 |
47 | Primary atrial arrhythmia (HP:0001692) | 3.17612761 |
48 | Myopathic facies (HP:0002058) | 3.14816497 |
49 | Ragged-red muscle fibers (HP:0003200) | 3.14293717 |
50 | Abnormality of alanine metabolism (HP:0010916) | 3.14275272 |
51 | Hyperalaninemia (HP:0003348) | 3.14275272 |
52 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.14275272 |
53 | Muscle fiber splitting (HP:0003555) | 3.12099480 |
54 | Supraventricular arrhythmia (HP:0005115) | 3.09551742 |
55 | Type 1 muscle fiber predominance (HP:0003803) | 3.06148946 |
56 | Ketosis (HP:0001946) | 3.05267005 |
57 | Dilated cardiomyopathy (HP:0001644) | 3.03893877 |
58 | Lethargy (HP:0001254) | 3.02146285 |
59 | Abnormal gallbladder physiology (HP:0012438) | 3.01483569 |
60 | Cholecystitis (HP:0001082) | 3.01483569 |
61 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.97560416 |
62 | Syncope (HP:0001279) | 2.94280523 |
63 | Conjunctival hamartoma (HP:0100780) | 2.85757201 |
64 | Abnormality of glycine metabolism (HP:0010895) | 2.84571501 |
65 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.84571501 |
66 | Microvesicular hepatic steatosis (HP:0001414) | 2.84450246 |
67 | Pheochromocytoma (HP:0002666) | 2.81991476 |
68 | Right ventricular cardiomyopathy (HP:0011663) | 2.79048666 |
69 | Generalized aminoaciduria (HP:0002909) | 2.77826271 |
70 | Neck muscle weakness (HP:0000467) | 2.77580342 |
71 | Myokymia (HP:0002411) | 2.74625520 |
72 | Neuroendocrine neoplasm (HP:0100634) | 2.67293277 |
73 | Distal arthrogryposis (HP:0005684) | 2.63293999 |
74 | EMG: myopathic abnormalities (HP:0003458) | 2.61373511 |
75 | Prolonged QT interval (HP:0001657) | 2.59971161 |
76 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.59576689 |
77 | Optic disc pallor (HP:0000543) | 2.58633830 |
78 | Muscle stiffness (HP:0003552) | 2.57757715 |
79 | Distal lower limb muscle weakness (HP:0009053) | 2.56471075 |
80 | Hyporeflexia of lower limbs (HP:0002600) | 2.54485505 |
81 | Ventricular fibrillation (HP:0001663) | 2.51061609 |
82 | Subaortic stenosis (HP:0001682) | 2.50766185 |
83 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.50766185 |
84 | Glycosuria (HP:0003076) | 2.50325978 |
85 | Abnormality of urine glucose concentration (HP:0011016) | 2.50325978 |
86 | Ventricular arrhythmia (HP:0004308) | 2.46414230 |
87 | Cerebral hypomyelination (HP:0006808) | 2.44824864 |
88 | Metabolic acidosis (HP:0001942) | 2.44573945 |
89 | Myotonia (HP:0002486) | 2.43703765 |
90 | * CNS demyelination (HP:0007305) | 2.43188924 |
91 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.41817210 |
92 | Leukodystrophy (HP:0002415) | 2.41094944 |
93 | Renal Fanconi syndrome (HP:0001994) | 2.40871077 |
94 | Bundle branch block (HP:0011710) | 2.40870668 |
95 | Proximal tubulopathy (HP:0000114) | 2.39534506 |
96 | Vomiting (HP:0002013) | 2.39379795 |
97 | Hyperglycinemia (HP:0002154) | 2.38341850 |
98 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.37442098 |
99 | Nausea (HP:0002018) | 2.36750006 |
100 | Asymmetric septal hypertrophy (HP:0001670) | 2.34253869 |
101 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.26917330 |
102 | Methylmalonic aciduria (HP:0012120) | 2.24576531 |
103 | Respiratory difficulties (HP:0002880) | 2.22500157 |
104 | Neoplasm of head and neck (HP:0012288) | 2.21414887 |
105 | Esophageal neoplasm (HP:0100751) | 2.21414887 |
106 | Cholelithiasis (HP:0001081) | 2.19576609 |
107 | Increased connective tissue (HP:0009025) | 2.19316094 |
108 | Abnormality of serum amino acid levels (HP:0003112) | 2.17447559 |
109 | EMG: neuropathic changes (HP:0003445) | 2.17388396 |
110 | Progressive external ophthalmoplegia (HP:0000590) | 2.15314689 |
111 | Neoplasm of the adrenal gland (HP:0100631) | 2.14628976 |
112 | Heart block (HP:0012722) | 2.14568827 |
113 | Gout (HP:0001997) | 2.07190332 |
114 | Abnormal gallbladder morphology (HP:0012437) | 2.06019689 |
115 | Cerebral palsy (HP:0100021) | 2.05985184 |
116 | * Emotional lability (HP:0000712) | 2.05515355 |
117 | Multiple enchondromatosis (HP:0005701) | 2.05191907 |
118 | Atrioventricular block (HP:0001678) | 2.03772309 |
119 | Abnormal atrioventricular conduction (HP:0005150) | 2.01060433 |
120 | Athetosis (HP:0002305) | 2.00860710 |
121 | Abnormal EKG (HP:0003115) | 2.00168151 |
122 | Difficulty running (HP:0009046) | 1.98404551 |
123 | Testicular atrophy (HP:0000029) | 1.98024893 |
124 | Progressive muscle weakness (HP:0003323) | 1.93161127 |
125 | Abnormality of the foot musculature (HP:0001436) | 1.91325751 |
126 | Fetal akinesia sequence (HP:0001989) | 1.90813225 |
127 | Increased variability in muscle fiber diameter (HP:0003557) | 1.86906439 |
128 | Limb-girdle muscle atrophy (HP:0003797) | 1.86601404 |
129 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.86536345 |
130 | Malignant hyperthermia (HP:0002047) | 1.84936939 |
131 | Resting tremor (HP:0002322) | 1.83531857 |
132 | Type I transferrin isoform profile (HP:0003642) | 1.77861066 |
133 | Tetraplegia (HP:0002445) | 1.77339822 |
134 | Ankle clonus (HP:0011448) | 1.74096310 |
135 | Deep venous thrombosis (HP:0002625) | 1.72473658 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 5.22946930 |
2 | OBSCN | 4.01311697 |
3 | LMTK2 | 4.01194891 |
4 | PDK3 | 3.76447699 |
5 | PDK4 | 3.76447699 |
6 | MYLK | 3.68934771 |
7 | TTN | 3.33354786 |
8 | NEK1 | 3.28129713 |
9 | PHKG2 | 3.16376700 |
10 | PHKG1 | 3.16376700 |
11 | NME2 | 2.47611977 |
12 | NME1 | 2.47102704 |
13 | PKN2 | 2.45981495 |
14 | PBK | 1.97582869 |
15 | PINK1 | 1.94536946 |
16 | PDK2 | 1.90214203 |
17 | TESK1 | 1.88915610 |
18 | WNK4 | 1.84527692 |
19 | TRIB3 | 1.79644211 |
20 | MAP3K12 | 1.69244896 |
21 | VRK2 | 1.65328422 |
22 | EIF2AK1 | 1.62357516 |
23 | TLK1 | 1.60652043 |
24 | TIE1 | 1.49888229 |
25 | PAK6 | 1.48897506 |
26 | ILK | 1.48557557 |
27 | MUSK | 1.43173440 |
28 | PRKD3 | 1.42913853 |
29 | UHMK1 | 1.42753204 |
30 | PIK3CA | 1.40471072 |
31 | GRK7 | 1.40455129 |
32 | STK16 | 1.30839881 |
33 | MAP3K11 | 1.29156400 |
34 | STK24 | 1.29150628 |
35 | CCNB1 | 1.28797094 |
36 | EIF2AK3 | 1.26401132 |
37 | KDR | 1.26138088 |
38 | CSNK1G3 | 1.26079860 |
39 | MAP2K4 | 1.23707919 |
40 | MARK1 | 1.21024506 |
41 | DAPK3 | 1.20477021 |
42 | DMPK | 1.17145537 |
43 | CAMK2D | 1.15144714 |
44 | FGFR4 | 1.08417987 |
45 | PRPF4B | 1.07789240 |
46 | STK38L | 1.02837963 |
47 | CDK19 | 0.97783876 |
48 | STK39 | 0.96416909 |
49 | CSNK1A1L | 0.92462014 |
50 | CSNK1G2 | 0.90744340 |
51 | ABL2 | 0.90453595 |
52 | MAP2K3 | 0.83703301 |
53 | CSNK1G1 | 0.83651126 |
54 | FLT3 | 0.83320494 |
55 | MINK1 | 0.80867710 |
56 | CAMK2G | 0.80559669 |
57 | MAPKAPK3 | 0.77091906 |
58 | MAP3K5 | 0.77044802 |
59 | MAPK12 | 0.73309394 |
60 | RPS6KB2 | 0.72605047 |
61 | CDK18 | 0.72503561 |
62 | MAP2K6 | 0.72460622 |
63 | EPHA3 | 0.71994960 |
64 | NEK9 | 0.70406082 |
65 | CDK11A | 0.70003818 |
66 | CDK15 | 0.69142152 |
67 | PAK3 | 0.68989185 |
68 | ERBB3 | 0.68533585 |
69 | BUB1 | 0.67881577 |
70 | CAMK2A | 0.67105691 |
71 | MAP3K4 | 0.66218307 |
72 | CDK14 | 0.64852880 |
73 | RIPK1 | 0.62121961 |
74 | LIMK1 | 0.61358194 |
75 | DYRK1B | 0.59845309 |
76 | ROCK1 | 0.59553138 |
77 | DYRK1A | 0.57590774 |
78 | PRKD1 | 0.56655344 |
79 | ZAK | 0.55236706 |
80 | DAPK2 | 0.54696424 |
81 | ROCK2 | 0.53723202 |
82 | FGFR3 | 0.53680052 |
83 | WEE1 | 0.52926332 |
84 | CDK5 | 0.52816768 |
85 | ARAF | 0.52669286 |
86 | CAMKK1 | 0.52350778 |
87 | ALK | 0.51703415 |
88 | CAMK1 | 0.51317913 |
89 | BRAF | 0.51000517 |
90 | MAPKAPK5 | 0.50734589 |
91 | PRKACA | 0.50067446 |
92 | OXSR1 | 0.48843110 |
93 | MAP3K7 | 0.48709980 |
94 | PRKAA1 | 0.48418631 |
95 | RPS6KB1 | 0.47028807 |
96 | SRPK1 | 0.46886604 |
97 | CSNK1E | 0.43096521 |
98 | PIM2 | 0.42983866 |
99 | PRKAA2 | 0.42630926 |
100 | PRKACG | 0.42567876 |
101 | CAMK4 | 0.42502155 |
102 | PRKACB | 0.42352514 |
103 | PRKG2 | 0.41814979 |
104 | MST1R | 0.40513942 |
105 | SIK3 | 0.38126627 |
106 | ADRBK1 | 0.37477485 |
107 | RPS6KA3 | 0.37140840 |
108 | TRIM28 | 0.36296624 |
109 | MAPK10 | 0.35937453 |
110 | CAMK2B | 0.35647231 |
111 | PDK1 | 0.35572867 |
112 | AKT2 | 0.35345766 |
113 | NEK6 | 0.35291019 |
114 | CSNK1A1 | 0.34941935 |
115 | STK4 | 0.34673649 |
116 | MAP2K1 | 0.34269008 |
117 | PTK2B | 0.33667172 |
118 | GRK5 | 0.32149242 |
119 | PDPK1 | 0.31832243 |
120 | CDK9 | 0.31425922 |
121 | EPHA4 | 0.30874239 |
122 | PIK3CG | 0.30757299 |
123 | EIF2AK2 | 0.30425682 |
124 | FER | 0.29437281 |
125 | RPS6KL1 | 0.28920391 |
126 | RPS6KC1 | 0.28920391 |
127 | CASK | 0.28518994 |
128 | MAPK11 | 0.28425547 |
129 | AURKA | 0.28419927 |
130 | SMG1 | 0.28216363 |
131 | VRK1 | 0.28196487 |
132 | MAP2K7 | 0.27972156 |
133 | MAPK4 | 0.27890322 |
134 | SCYL2 | 0.24656008 |
135 | CSNK2A2 | 0.23959095 |
136 | PRKCG | 0.22968909 |
137 | TTK | 0.22412394 |
138 | CSNK2A1 | 0.21574382 |
139 | LRRK2 | 0.20611504 |
140 | NTRK3 | 0.20504516 |
141 | PRKCE | 0.20167441 |
142 | RPS6KA6 | 0.19890620 |
143 | DAPK1 | 0.19874133 |
144 | STK38 | 0.18991023 |
145 | TESK2 | 0.18327789 |
146 | PRKCA | 0.16108989 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.14132500 |
2 | * Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.12021083 |
3 | Parkinsons disease_Homo sapiens_hsa05012 | 3.84310778 |
4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.77200608 |
5 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.46577849 |
6 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.93663208 |
7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.91196757 |
8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.86731580 |
9 | Alzheimers disease_Homo sapiens_hsa05010 | 2.74809541 |
10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.73057863 |
11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.68795663 |
12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.63240067 |
13 | Huntingtons disease_Homo sapiens_hsa05016 | 2.52249978 |
14 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.48251197 |
15 | * Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.45647305 |
16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.23061229 |
17 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.12637026 |
18 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.08677638 |
19 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.78639762 |
20 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.60140340 |
21 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.59957778 |
22 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.52211052 |
23 | Ribosome_Homo sapiens_hsa03010 | 1.52147360 |
24 | Proteasome_Homo sapiens_hsa03050 | 1.49074881 |
25 | Peroxisome_Homo sapiens_hsa04146 | 1.43110112 |
26 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.38038381 |
27 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.35867870 |
28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.33652875 |
29 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.32143081 |
30 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.29681414 |
31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.27432259 |
32 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.20720796 |
33 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.10199072 |
34 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.09588613 |
35 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.08334676 |
36 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.06445739 |
37 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.99477879 |
38 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.91574876 |
39 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.89588577 |
40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.88427155 |
41 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.86292635 |
42 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.84795912 |
43 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.82344527 |
44 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.79274034 |
45 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.78476324 |
46 | Sulfur relay system_Homo sapiens_hsa04122 | 0.78069773 |
47 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.77233694 |
48 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.76690865 |
49 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.75388719 |
50 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.73472279 |
51 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.71739578 |
52 | Galactose metabolism_Homo sapiens_hsa00052 | 0.67713904 |
53 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.67541806 |
54 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.66984702 |
55 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.66346784 |
56 | Base excision repair_Homo sapiens_hsa03410 | 0.63363586 |
57 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.60498553 |
58 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.58655017 |
59 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.57596312 |
60 | Other glycan degradation_Homo sapiens_hsa00511 | 0.56535237 |
61 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.55915188 |
62 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.53463387 |
63 | GABAergic synapse_Homo sapiens_hsa04727 | 0.52196756 |
64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.51826538 |
65 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.51798796 |
66 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.50587671 |
67 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.49430030 |
68 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.48154580 |
69 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.48029133 |
70 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.47286143 |
71 | RNA polymerase_Homo sapiens_hsa03020 | 0.46670747 |
72 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.45680652 |
73 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.44895220 |
74 | Circadian rhythm_Homo sapiens_hsa04710 | 0.44867145 |
75 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.43789133 |
76 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.43384752 |
77 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.43163500 |
78 | Bile secretion_Homo sapiens_hsa04976 | 0.41547769 |
79 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.38453252 |
80 | Histidine metabolism_Homo sapiens_hsa00340 | 0.35649442 |
81 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.33507540 |
82 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.33137191 |
83 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.32010975 |
84 | Insulin secretion_Homo sapiens_hsa04911 | 0.31885633 |
85 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.31696631 |
86 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.31675985 |
87 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.31416947 |
88 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.30271651 |
89 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.29402720 |
90 | Long-term potentiation_Homo sapiens_hsa04720 | 0.27669342 |
91 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.26374449 |
92 | Purine metabolism_Homo sapiens_hsa00230 | 0.26271816 |
93 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.26037756 |
94 | Nicotine addiction_Homo sapiens_hsa05033 | 0.25072006 |
95 | DNA replication_Homo sapiens_hsa03030 | 0.23994858 |
96 | Spliceosome_Homo sapiens_hsa03040 | 0.22751478 |
97 | Renin secretion_Homo sapiens_hsa04924 | 0.22421699 |
98 | Retinol metabolism_Homo sapiens_hsa00830 | 0.22007383 |
99 | Insulin resistance_Homo sapiens_hsa04931 | 0.21255588 |
100 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.21089402 |
101 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.20972855 |
102 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.18686055 |
103 | Lysine degradation_Homo sapiens_hsa00310 | 0.16816874 |
104 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.13862697 |
105 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.13664945 |
106 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.11076264 |
107 | Protein export_Homo sapiens_hsa03060 | 0.10426278 |
108 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.09043101 |
109 | Viral myocarditis_Homo sapiens_hsa05416 | 0.08243916 |
110 | Mismatch repair_Homo sapiens_hsa03430 | 0.08154468 |
111 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.06509572 |
112 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.05654960 |
113 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.05259675 |
114 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.01015712 |
115 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0071648 |
116 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | -0.0014547 |